Pfizer
PFE
PFE
2,886 hedge funds and large institutions have $106B invested in Pfizer in 2024 Q3 according to their latest regulatory filings, with 191 funds opening new positions, 1,235 increasing their positions, 1,185 reducing their positions, and 126 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,886
Holders Change
+33
Holders Change %
+1.16%
% of All Funds
41.75%
Holding in Top 10
40
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+25%
% of All Funds
0.58%
New
191
Increased
1,235
Reduced
1,185
Closed
126
Calls
$2.51B
Puts
$4.05B
Net Calls
-$1.54B
Net Calls Change
-$4.73M
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$421M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$372M |
| 3 |
Barclays
London,
United Kingdom
|
+$343M |
| 4 |
BlackRock
New York
|
+$336M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$284M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$997M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$357M |
| 3 |
Goldman Sachs
New York
|
-$263M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$261M |
| 5 |
DCP
D1 Capital Partners
New York
|
-$213M |
